Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome.
Kluijt I, de Jong D, Teertstra HJ, Axwijk PH, Gille JJ, Bell K, van Rens A, van der Velden AW, Middelton L, Horenblas S. Kluijt I, et al. Among authors: van rens a, van der velden aw. Clin Genet. 2009 Jun;75(6):537-43. doi: 10.1111/j.1399-0004.2009.01159.x. Epub 2009 Mar 23. Clin Genet. 2009. PMID: 19320655
Mistaken identity of widely used esophageal adenocarcinoma cell line TE-7.
Boonstra JJ, van der Velden AW, Beerens EC, van Marion R, Morita-Fujimura Y, Matsui Y, Nishihira T, Tselepis C, Hainaut P, Lowe AW, Beverloo BH, van Dekken H, Tilanus HW, Dinjens WN. Boonstra JJ, et al. Among authors: van dekken h, van der velden aw, van marion r. Cancer Res. 2007 Sep 1;67(17):7996-8001. doi: 10.1158/0008-5472.CAN-07-2064. Cancer Res. 2007. PMID: 17804709
Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear beta-catenin expression.
Koppert LB, van der Velden AW, van de Wetering M, Abbou M, van den Ouweland AM, Tilanus HW, Wijnhoven BP, Dinjens WN. Koppert LB, et al. Among authors: van den ouweland am, van der velden aw, van de wetering m. Br J Cancer. 2004 Feb 23;90(4):892-9. doi: 10.1038/sj.bjc.6601589. Br J Cancer. 2004. PMID: 14970870 Free PMC article.
70-Gene signature-guided adjuvant systemic treatment adjustments in early-stage ER+ breast cancer patients: 7-year follow-up of a prospective multicenter cohort study.
Verreck EEF, Kuijer A, van Steenhoven JEC, Volders JH, van der Velden AWG, Siesling S, Timmer-Bonte ANH, Smilde TJ, Imholz ALT, Blanken-Peeters CFJM, de Valk B, Vrijaldenhoven S, Lastdrager WB, Haringhuizen AW, Hunting JCB, Hovenga S, Nieboer P, Zuetenhorst HM, Tetteroo GWM, Smorenburg CH, van Maaren MC, van Dalen T. Verreck EEF, et al. Among authors: van der velden awg. Breast Cancer Res Treat. 2024 Sep 30. doi: 10.1007/s10549-024-07496-3. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39349887
Did aetiology matter in illness duration and complications in patients presenting in primary care with acute respiratory tract infections early in the COVID-19 pandemic: An observational study in nine countries.
Venekamp RP, Eijkemans MJC, Zuithoff NPA, Böhmer F, Chlabicz S, Colliers A, García-Sangenís A, Malania L, Pauer J, Tomacinschii A, Verheij TJ, Goossens H, Vellinga A, Butler CC, van der Velden AW. Venekamp RP, et al. Among authors: van der velden aw. Eur J Gen Pract. 2024 Dec;30(1):2376084. doi: 10.1080/13814788.2024.2376084. Epub 2024 Jul 12. Eur J Gen Pract. 2024. PMID: 38995056 Free PMC article.
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
van der Voort A, Louis FM, van Ramshorst MS, Kessels R, Mandjes IA, Kemper I, Agterof MJ, van der Steeg WA, Heijns JB, van Bekkum ML, Siemerink EJ, Kuijer PM, Scholten A, Wesseling J, Vrancken Peeters MTFD, Mann RM, Sonke GS; Dutch Breast Cancer Research Group. van der Voort A, et al. Lancet Oncol. 2024 May;25(5):603-613. doi: 10.1016/S1470-2045(24)00104-9. Epub 2024 Apr 5. Lancet Oncol. 2024. PMID: 38588682 Clinical Trial.
Tailored anticoagulant treatment after a first venous thromboembolism: protocol of the Leiden Thrombosis Recurrence Risk Prevention (L-TRRiP) study - cohort-based randomised controlled trial.
Burggraaf-van Delft JLI, van Rein N, Bemelmans RHH, van den Berg JK, Bruggeman CY, Cloos-van Balen M, Coppens M, Eefting M, Ende-Verhaar Y, van Es N, van Guldener C, de Jong WK, Kleijwegt F, Koster T, Kroon C, Kuipers S, Leentjens J, Luijten D, Mairuhu ATA, Meijer K, van de Ree MA, Roos R, Schrover I, Swart-Heikens J, van der Velden AWG, van den Akker-van Marle EM, le Cessie S, Geersing GJ, Middeldorp S, Huisman MV, Klok FA, Cannegieter SC; L-TRRiP investigators. Burggraaf-van Delft JLI, et al. Among authors: van der velden awg. BMJ Open. 2024 Mar 23;14(3):e078676. doi: 10.1136/bmjopen-2023-078676. BMJ Open. 2024. PMID: 38521524 Free PMC article.
Communication training for general practitioners aimed at improving antibiotic prescribing: a controlled before-after study in multicultural Dutch cities.
Lescure DLA, Erdem Ö, Nieboer D, Huijser van Reenen N, Tjon-A-Tsien AML, van Oorschot W, Brouwer R, Vos MC, van der Velden AW, Richardus JH, Voeten HACM. Lescure DLA, et al. Among authors: van der velden aw. Front Med (Lausanne). 2024 Jan 23;11:1279704. doi: 10.3389/fmed.2024.1279704. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38323031 Free PMC article.
Using microbiological data to improve the use of antibiotics for respiratory tract infections: A protocol for an individual patient data meta-analysis.
Boateng I, Stuart B, Becque T, Barrett B, Bostock J, Bruyndonckx R, Carr-Knox L, Ciccone EJ, Coenen S, Ebell M, Gillespie D, Hayward G, Hedin K, Hood K, Lau TMM, Little P, Merenstein D, Mulogo E, Ordóñez-Mena J, Muir P, Samuel K, Shaikh N, Tonner S, van der Velden AW, Verheij T, Wang K, Hay AD, Francis N. Boateng I, et al. Among authors: van der velden aw. PLoS One. 2023 Nov 27;18(11):e0294845. doi: 10.1371/journal.pone.0294845. eCollection 2023. PLoS One. 2023. PMID: 38011202 Free PMC article.
119 results